Skip to content

Vibration Training for Patients With Chronic Stroke

Effectiveness of Vibration Training on Muscle Strength, Functional Recovery, Quality of Life, and Self-Esteem in Patients With Chronic Stroke: A Randomized Controlled Trial

Status
Completed
Phases
Unknown
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT07554794
Enrollment
39
Registered
2026-04-28
Start date
2023-04-18
Completion date
2025-03-31
Last updated
2026-04-28

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Stroke

Brief summary

A 4-week program of vibration training in a seated position combined with conventional rehabilitation led to significant improvements in unaffected side lower limb muscle strength, functional recovery, quality of life, and self-esteem in patients with chronic stroke. No significant improvement was noted in affected side lower limb muscle strength. These findings highlight the integration of localized muscle vibration training into rehabilitation as a promising strategy for treating individuals with chronic stroke.

Interventions

seated vibration training

Sponsors

CHIA-HUEI LIN, PhD
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
20 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* hospitalization for chronic stroke (≥ 6 months since onset) * age ≥ 20 years * Mini-Mental State Examination score ≥ 24 * able to communicate verbally or nonverbally and understand Mandarin or Taiwanese * modified Rankin Scale of 2 to 4 * Brunnstrom stage ≥ 3 * willing to participate with consent to randomization

Exclusion criteria

* transient ischemic attack * neuromuscular or musculoskeletal disorders of the both upper or lower limbs or history of orthopedic surgery within the past 6 months * deep vein thrombosis * pacemaker implantation * unstable conditions, including cardiovascular disease, cancer, end-stage renal disease requiring hemodialysis, or psychiatric disorders

Design outcomes

Primary

MeasureTime frame
muscle strength measured by manual muscle testFrom enrollment to the end of treatment at 4 weeks
functional recovery measured by Barthel indexFrom enrollment to the end of treatment at 4 weeks
functional recovery measured by Stroke Impact ScaleFrom enrollment to the end of treatment at 4 weeks

Secondary

MeasureTime frame
quality of life measured by short form 12 health surveyFrom enrollment to the end of treatment at 4 weeks
self-esteem measured by Rosenberg Self-Esteem ScaleFrom enrollment to the end of treatment at 4 weeks

Countries

Taiwan

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Apr 29, 2026